• Return to Headlines

Shares of Agenus Inc Fall to a New 52-Week Low

By Amy Schwartz

Agenus Inc (NASDAQ:AGEN) traded at a new 52-week low today of $2.77. This new low was reached on below average trading volume as 426,000 shares traded hands, while the average 30-day volume is approximately 1.3 million shares.

Over the past year, Agenus Inchas traded in a range of $2.77 to $6.19 and are now at $2.78. Over the last five market days, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has declined 2.7%.

There is potential upside of 151.8% for shares of Agenus Inc based on a current price of $2.78 and an average consensus analyst price target of $7.00. The stock should run into initial resistance at its 50-day moving average (MA) of $3.65 and subsequent resistance at its 200-day MA of $4.04.

Agenus, Inc. develops vaccines. The Company researches vaccines for brain cancer, kidney cancer, herpes, lung cancer, melanoma, malaria, shingles, and Alzheimer's disease.

SmarTrend recommended that its subscribers protect gains by selling shares of Agenus Inc on March 22nd, 2018 by issuing a Downtrend alert when the shares were trading at $5.22. Since that call, shares of Agenus Inc have fallen 45.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows agenus inc

Ticker(s): AGEN